299 More recent studies have found that GLP-1R agonists can improve lung function in patients/animals with lung pathology and could be a new treatment for patients with lung diseases such as chronic obstructive pulmonary disease and asthma
GLP-1 stimulates glucose-dependent insulin secretion and suppresses glucagon release, helping lower blood sugar, slows gastric emptying, and promotes satiety
In the SURMOUNT-1 trial, tirzepatide produced dose-dependent weight reductions, with average losses approaching or exceeding ~20% at higher doses in adults with obesity who did not have diabetes, numbers that markedly exceed historical pharmacotherapy benchmarks
Related Articles: - Retatrutide: Complete Guide - Retatrutide Side Effects - How to Get Retatrutide - Best Peptides for Weight Loss - Getting Started with Peptides Helpful Tools Related Articles Retatrutide Availability & Timeline Retatrutide is expected to receive FDA approval in mid-2027 with pharmacy availability in late 2027
First, use our free wellness platform to find out what your BMI is
Your Tirzepatide medication Home delivery or local pharmacy pickup, depending on your plan
